- Drug Pipelines
- July 2020
- 63 Pages
Global
From €1922EUR$2,000USD£1,650GBP
- Drug Pipelines
- July 2020
- 72 Pages
Global
From €1922EUR$2,000USD£1,650GBP
- Drug Pipelines
- July 2020
- 50 Pages
Global
From €1922EUR$2,000USD£1,650GBP
- Report
- April 2023
- 95 Pages
Global
€3363EUR$3,500USD£2,887GBP
- Report
- November 2023
- 86 Pages
Global
From €3500EUR$3,902USD£3,110GBP
- Report
- May 2023
- 99 Pages
Global
From €3500EUR$3,902USD£3,110GBP
- Report
- August 2021
- 74 Pages
Global
From €3200EUR$3,568USD£2,843GBP
- Report
- July 2022
- 110 Pages
Global
From €1922EUR$2,000USD£1,650GBP
- Drug Pipelines
- March 2021
Global
From €1922EUR$2,000USD£1,650GBP
- Report
- March 2024
- 132 Pages
Global
From €913EUR$950USD£784GBP
- Report
- May 2023
- 233 Pages
Global
From €5506EUR$5,730USD£4,726GBP
- Report
- January 2023
- 210 Pages
Global
From €5506EUR$5,730USD£4,726GBP
- Report
- February 2022
- 274 Pages
Global
From €5926EUR$6,168USD£5,088GBP
- Report
- May 2023
- 160 Pages
Global
From €5764EUR$5,999USD£4,948GBP
The Muscle Relaxant market is a subset of the Central Nervous System Drugs market. Muscle relaxants are drugs that are used to reduce muscle spasms, tension, and stiffness. They are commonly used to treat conditions such as muscle spasms, neck and back pain, fibromyalgia, and multiple sclerosis. Muscle relaxants can be divided into two categories: non-depolarizing and depolarizing. Non-depolarizing muscle relaxants are used to reduce muscle spasms and tension, while depolarizing muscle relaxants are used to reduce muscle stiffness.
The Muscle Relaxant market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. These companies offer a range of products, including non-depolarizing and depolarizing muscle relaxants, as well as combination products. Show Less Read more